Literature DB >> 25097073

Beyond current guidelines: reduction in minimum administered radiopharmaceutical activity with preserved diagnostic image quality in pediatric hepatobiliary scintigraphy.

Frederic Fahey1, Katherine Zukotynski, David Zurakowski, Robert Markelewicz, Anthony Falone, Marie Vitello, Xinhua Cao, Frederick Grant, Laura Drubach, A Hans Vija, Manojeet Bhattacharya, Xinhong Ding, Zvi Bar-Sever, Michael Gelfand, S Ted Treves.   

Abstract

PURPOSE: To determine if the minimum administered radiopharmaceutical activity for hepatobiliary scintigraphy can be reduced while preserving diagnostic image quality using enhanced planar processing (EPP).
METHODS: A total of 40 infants between 10 and 270 days old (body mass 2.2 - 6.5 kg) had hepatobiliary scintigraphy during the period 2004 - 2010 following the intravenous administration of either (99m)Tc-mebrofenin (18 patients) or (99m)Tc-disofenin (22 patients). Due to the small size of these patients, they all received the minimum administered activity of 18.5 MBq consistent with the North American Consensus Guidelines. Six nuclear medicine physicians subjectively graded the acceptability of the image quality for clinical interpretation using a four-point scale (not acceptable, fair, good, excellent). Each physician independently graded seven image sets including the original study (full activity) and simulated reduced activity studies using binomial subsampling (50% of full activity, 25% of full activity and activity reduced by weight), with and without EPP.
RESULTS: For full-activity studies, 98% were deemed acceptable by the six physicians for clinical interpretation. The percentages of acceptable 50% reduced activity studies with and without EPP were not significantly different from the percentage of acceptable full-activity studies (P = 0.193 and P = 0.998, respectively). The percentage of acceptable 25% reduced activity studies without EPP was significantly different from the percentage of acceptable full-activity studies (P < 0.001); however, this difference vanished when EPP was applied (P = 0.482). The activity reduced by weight ranged from 1.85 to 4.81 MBq (10% to 26% of full dose) and the percentages of acceptable studies with and without EPP were significantly different from the percentage of acceptable full-activity studies (P < 0.001 and P = 0.02, respectively).
CONCLUSION: Clinically interpretable hepatobiliary scintigraphy images can be obtained in infants when the minimum administered activity is substantially reduced. Without EPP, clinically acceptable images may be produced with a reduction of 50%, and with EPP, a reduction of 75% or more may be possible.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25097073     DOI: 10.1007/s00259-014-2860-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  8 in total

1.  Pediatric radiopharmaceutical doses: new guidelines.

Authors:  S Ted Treves; Marguerite T Parisi; Michael J Gelfand
Journal:  Radiology       Date:  2011-11       Impact factor: 11.105

2.  SNM practice guideline for hepatobiliary scintigraphy 4.0.

Authors:  Mark Tulchinsky; Brian W Ciak; Dominique Delbeke; Andrew Hilson; Kelly Anne Holes-Lewis; Michael G Stabin; Harvey A Ziessman
Journal:  J Nucl Med Technol       Date:  2010-11-15

3.  The new EANM paediatric dosage card.

Authors:  M Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09       Impact factor: 9.236

4.  Improved lesion detection from spatially adaptive, minimally complex, Pixon reconstruction of planar scintigraphic images.

Authors:  Carl A Wesolowski; Amos Yahil; Richard C Puetter; Paul S Babyn; David L Gilday; Mustafa Z Khan
Journal:  Comput Med Imaging Graph       Date:  2005-01-13       Impact factor: 4.790

5.  Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines.

Authors:  Michael J Gelfand; Marguerite T Parisi; S Ted Treves
Journal:  J Nucl Med       Date:  2011-01-13       Impact factor: 10.057

Review 6.  Hepatobiliary scintigraphy in infancy.

Authors:  R Howman-Giles; R Uren; E Bernard; S Dorney
Journal:  J Nucl Med       Date:  1998-02       Impact factor: 10.057

7.  Minimizing and communicating radiation risk in pediatric nuclear medicine.

Authors:  Frederic H Fahey; S Ted Treves; S James Adelstein
Journal:  J Nucl Med       Date:  2011-07-15       Impact factor: 10.057

8.  Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America.

Authors:  S Ted Treves; Royal T Davis; Frederic H Fahey
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

  8 in total
  2 in total

Review 1.  Dose Estimation in Pediatric Nuclear Medicine.

Authors:  Frederic H Fahey; Alison B Goodkind; Donika Plyku; Kitiwat Khamwan; Shannon E O'Reilly; Xinhua Cao; Eric C Frey; Ye Li; Wesley E Bolch; George Sgouros; S Ted Treves
Journal:  Semin Nucl Med       Date:  2016-11-09       Impact factor: 4.446

2.  A randomized, double-blind, crossover comparison of novel continuous bed motion versus traditional bed position whole-body PET/CT imaging.

Authors:  Imke Schatka; Desiree Weiberg; Stephanie Reichelt; Nicole Owsianski-Hille; Thorsten Derlin; Georg Berding; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-06       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.